Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$305,267
+$8,658 QoQ
Shares Held
843
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,540
of 3,140 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BCS Wealth Management holds $7,700,051 across 8 Drug Manufacturers - General names. AMGN ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,962 | $2,353,281 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,887 | $2,041,479 | |
| 3 | JNJ |
Johnson & Johnson
|
3,739 | $949,593 | |
| 4 | ABBV |
AbbVie Inc.
|
3,535 | $889,547 | |
| 5 | PFE |
Pfizer Inc
|
26,000 | $626,080 | |
| 6 | AMGN |
Amgen Inc
This page
|
843 | $305,267 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,112 | $294,553 | |
| 8 | NVS |
Novartis AG
|
1,533 | $240,251 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,267 | 843 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $296,609 | 843 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $551,844 | 1,686 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $222,938 | 790 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $263,015 | 942 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $246,124 | 790 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $206,687 | 793 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $255,512 | 793 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $247,772 | 793 | Shares | Sole | 2024-07-16 | |
| 2023-12-31 | $199,597 | 693 | Shares | Sole | 2024-01-11 | |
| No filing history on record for this holder in this stock. | ||||||